<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://www.taxtmi.com/rss_sitemap/rss_feed_blog.xsl?v=1750492856"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Clarification on availability of benefit under Focus Product Scheme on the export of item &#039;OMEPRAZOLE AND LANSOPRAZOLE&#039;.</title>
    <link>https://www.taxtmi.com/circulars?id=54295</link>
    <description>Regional authorities are directed to grant Focus Product Scheme incentives for exports of finished dosage forms that use either Omeprazole or Lansoprazole as the active pharmaceutical ingredient, the Department of Pharmaceuticals having clarified the tariff entry covers the two distinct finished-dosage-form products rather than a combined formulated product.</description>
    <language>en-us</language>
    <pubDate>Wed, 17 Feb 2016 00:00:00 +0530</pubDate>
    <lastBuildDate>Fri, 19 Feb 2016 15:36:00 +0530</lastBuildDate>
    <generator>TaxTMI RSS Generator</generator>
    <atom:link href="https://www.taxtmi.com/rss_feed_blog?id=416838" rel="self" type="application/rss+xml"/>
    <item>
      <title>Clarification on availability of benefit under Focus Product Scheme on the export of item &#039;OMEPRAZOLE AND LANSOPRAZOLE&#039;.</title>
      <link>https://www.taxtmi.com/circulars?id=54295</link>
      <description>Regional authorities are directed to grant Focus Product Scheme incentives for exports of finished dosage forms that use either Omeprazole or Lansoprazole as the active pharmaceutical ingredient, the Department of Pharmaceuticals having clarified the tariff entry covers the two distinct finished-dosage-form products rather than a combined formulated product.</description>
      <category>Circulars</category>
      <law>DGFT</law>
      <pubDate>Wed, 17 Feb 2016 00:00:00 +0530</pubDate>
      <guid isPermaLink="true">https://www.taxtmi.com/circulars?id=54295</guid>
    </item>
  </channel>
</rss>